The University of California and Tobacco Funding: An Update Michael Ong October 24, 2007.

Slides:



Advertisements
Similar presentations
The Role of the IRB An Institutional Review Board (IRB) is a review committee established to help protect the rights and welfare of human research subjects.
Advertisements

VCOM Conflict of Interest Policy Overview of Financial Conflict of Interest Related to Research December 4, 2013.
Improving how your organisation supports the use of research evidence to inform policymaking.
Conflict of Interest (COI) Objectives: Provide an overview of financial conflict of interest (FCOI) related to research activities at Gillette Describe.
STATEMENT OF AUDITING STANDARDS 112 (SAS112) Communicating Internal Control Matters Identified in an Audit UC Riverside June 2007.
1 UMass Dartmouth Conflicts of Interest Policies UMass Dartmouth Liz Rodriguez February 17, 2011.
Campus Improvement Plans
Competing interests Jaideep A Gogtay MD Conflict of Interest Employee of Cipla Ltd.
Conflict of Interest: Dartmouth College. Why do we care about it ? Conflict of Interest in Research : Unbiased research: design, conduct, reporting Maintain.
Presented by: David E. Broome, Jr. Vice Chancellor and General Counsel Carl P.B. Mahler, II Executive Director, Office of Technology Transfer October 30,
Career Planning in Academic Medicine David Coleman, M.D. Faculty Development Seminar Tuesday, September 18, 2007.
The Institutional Review Board. What is an IRB? An IRB is committee set up by an institution to review, approve, and regulate research conducted under.
NIH Mentored Career Development Awards (K Series) Part 2 Thomas Mitchell, MPH Department of Epidemiology & Biostatistics University of California San Francisco.
Second-hand Smoke Study Sparks Controversy By Mike Wendling CNSNews.com London Bureau Chief May 16, 2003
1 UCDHS Vendor Relations Policy Development & Implementation Teresa Porter, CHC - Chief Compliance Officer David Levine, JD - Legal Counsel Allan Siefkin,
What is Public Health? Allyson Hall, PhD
Public Health Collaborations to Improve Health Outcomes: Healthy Aging Opportunities Lynda Anderson, PhD Director, Healthy Aging Program Centers for Disease.
HIGHLIGHTS FROM THE CALIFORNIA TOBACCO SURVEYS Elizabeth A. Gilpin, MS Principal Investigator 1999 California Tobacco Surveys Cancer Prevention and Control.
Page 1 CRAD F&A Waiver Process Change November 15, 2007.
Conflict of Interest Faculty & Staff of Instruction or Research Human Resources 2011.
Code of Ethics – Discussion Question
Fall 2014 Kate Walker, Vice President for Finance and Treasurer
Overview of the National Science Foundation (NSF) and the Major Research Instrumentation (MRI) Program Office of Integrative Activities National Science.
BRIEFING TO THE PORTFOLIO COMMITTEE ON THE DPSA’S RISK MANAGEMENT STRATEGY PRESENTATION TO THE PORTFOLIO COMMITTEE 12 MAY
Promoting Objectivity in Research by Managing, Reducing, or Eliminating Conflicts of Interest UT HOP UT HOP The University of Texas at Austin.
Building Partnerships with U.S. Universities William Lacy Vice Provost—University Outreach & International Programs.
Internal Auditing and Outsourcing
The University of California Sponsored Project Funding: Pre-Award Nancy R. Lewis Director, Sponsored Projects Administration University of California,
Environmental Issues and Cancer Prevention Strategies.
UNM and Health System Internal Audit Departments Internal Audit Department Orientation Manu Patel, Internal Audit Director Purvi Mody, Executive Director,
1 The Prevention Research Centers Program: The Case for Networks Eduardo Simoes, MD, MSc, MPH Program Director Prevention Research Centers National Center.
The University of North Carolina at Chapel Hill Fall Board of Visitors Meeting Friday, September 19, 2008 Development Update By Matthew G. Kupec Vice Chancellor.
U.S. Department of Agriculture Center for Nutrition Policy and Promotion Slides provided by the USDA Center for Nutrition Policy and Promotion.
Presented by: Melitta A. Johnson, MHA, August 7, 2015
+ Conflict of Interest in Physician-Industry Relationships.
PHS COI Policy Update Grace Park, COIOC Administrator Office of Research June 2012.
1 Eric G. Campbell, Ph.D. Assistant Professor Harvard Medical School Massachusetts General Hospital Commercialization in Academe: Lessons from the Life.
Disclosure of Financial Conflicts of Interest in Continuing Medical Education Michael D. Jibson, MD, PhD and Jennifer Seibert, MD University of Michigan.
Safeguarding Research Data Policy and Implementation Challenges Miguel Soldi February 24, 2006 THE UNIVERSITY OF TEXAS SYSTEM.
+ Role of Industry in Clinical Care, Research, and Education.
Acknowledgements and Conflicts of interest Dr Gurpreet Kaur Associate Professor Dept of Pharmacology Government Medical College Amritsar.
Office of Foundation Relations
Retha Britz Copyright 2013 All rights reserved for this presentation 1 Other important considerations for RECs Retha Britz.
Partners Conflict of Interest Policy and Reporting October 11, 2012.
Maryland’s Cigarette Restitution Program Georges C. Benjamin, MD FACP, Secretary Maryland Department of Health and Mental Hygiene November 2000 Protecting.
NOAA Cooperative Institutes John Cortinas, Ph.D. OAR Cooperative Institute Program, Program Manager NOAA Cooperative Institute Committee, Chairperson.
Copyright © Harvard Medical School. All Rights Reserved. Outside Activity Report: What Do I Need to Report?
Sara Lovell, CPCS Education Coordinator Providence Alaska Medical Center.
AAHRPP ACCREDITATION (Association for the Accreditation of Human Protection Programs)
AHRQ 2009 Annual Conference Do Ask, Do Tell: Best Practices in Conflict of Interest Policies for Research, Publishing, and Recommendation-Making Non-Financial.
NIAMS Training Grant and Career Development Award Program Evaluation Presented by David Wofsy, M.D. Chairman Evaluation Working Group September 27, 2007.
Brian Smith Associate Vice Chancellor, Research Infrastructure and Operations Academic Senate Committee on Research December 15, 2014.
Background Results Conclusions / Policy Implications SHS causes approximately 38,000 deaths among nonsmokers in the U.S. each year (1,2) Workplace smoking.
Second Annual Medical Research Summit March 25, 2002 Washington, D.C.
1 Disclosure of Financial Interest in Sponsored Research Molly Stoufer Research and Institutional Integrity Office.
H ⊕ lger Schünemann, MD, PhD Professor and Chair, Dept. of Clinical Epidemiology & Biostatistics Professor of Medicine Michael Gent Chair in Healthcare.
1 Copyright © 2012 by Mosby, an imprint of Elsevier Inc. Copyright © 2008 by Mosby, Inc., an affiliate of Elsevier Inc. Chapter 39 The Advanced Practice.
Challenges in Promoting RCR: Reflections from a Public Funder´s Perspective Secretariat on Responsible Conduct of Research [Canadian Institutes of Health.
Corporate manipulation of environmental health research: A comparison of four industries Jenny White, MSc, MPH Lisa Bero, PhD Dept. of Clinical Pharmacy.
Marketing to the marginalized: Tobacco industry targeting of the homeless, mentally ill and injection drug users Dorie Apollonio, PhD, & Ruth E. Malone,
PUBLICATION PRINCIPLES for PUBLICATION PROFESSIONALS
Scientific and Scholarly Validity
Smokeasy: A case study of enforcement and penalties of smoke-free indoor air bans in workplaces and restaurants in three states Ryan Patrick, J.D. and.
Conflict of Interest Policy 4:35
UCR PRO Reviewer Placemat
Sneak Preview: The Revised PHS FCOI Regulations
Accountability and Internal Controls – Best Practices
Review of Ingredients Added to Cigarettes
Conflicts of Interest and Management Plans
STATEMENT OF AUDITING STANDARDS 112 (SAS112)
Presentation transcript:

The University of California and Tobacco Funding: An Update Michael Ong October 24, 2007

Academia & Research Funding Promotion Criteria teaching research and creative work professional competence and activity University and public service

Trends in Federal Research Spending From AAAS, 2008

Academia & Industry Funding

Relationship Between Industry Funding and Outcomes of Studies Close financial ties between industry sponsors and clinical investigators may influence the quality and outcome of clinical studies (Boyd et al, 2003) –Small amounts of funds have been shown to influence health professionals –Discovery of these influences also undermine public trust of clinical research The tobacco industry (TI) uses funding to suppress, manipulate, and distort scientific research –To support industry positions and counters scientific work (Barnes & Bero, 1996) –To cultivate credibility and generate positive public image (Malone & Bero, 2003)

Tobacco Industry (TI) Funding Center for Indoor Air Research (CIAR) –Central element of 2006 federal court ruling that TI violated Racketeer Influenced Corrupt Organizations (RICO) Act –"special reviewed" projects by lawyers outside of their "peer" review system Philip Morris External Research Program is a continuation of CIAR activity –Funded scientists are often same as those funded through CIAR (Hirschhorn, et al, 2001 & 2006)

Example: TI-Funding of Studies Using ACS Cancer Prevention Studies Data LeVois & Layard, 1995 concluded no cardiac risk from passive smoking Did not separate current smoking spouse from former smoking spouse, when comparing to never smoking spouse Exclusion of older CPS data and former smoking spouse shows 20% increase in cardiac risk from passive smoking (Steenland, et al, 1996) Enstrom & Kabat, 2003 Long-term follow up on LeVois & Layard data repeats same exposure misclassification error reports same conclusion of no cardiac risk from passive smoking Warned specifically by ACS that older CPS data used is inappropriate for passive smoking studies From Tong & Glantz, 2007

TI-Funding Bans: Issues Academic Integrity The tobacco industry has a history of, and continues to restrict and undermine academic freedom stringent and rigorous thresholds must be met before undertaking any restriction lower levels of safeguards are unlikely to result in adequate protection from manipulation by the tobacco industry

TI-Funding Bans at U.S. Academic Institutions Schools of Public Health Columbia University Harvard University John Hopkins University Loma Linda University Louisiana State University Ohio State University University of Arizona University of Iowa University of Medicine and Dentistry of New Jersey University of North Carolina University of Puerto Rico University of South Carolina Schools of Medicine Emory University Harvard University John Hopkins University Institutions & Hospitals Brigham and Women’s Hospital MD Anderson Cancer Center in Houston, Texas Massachusetts General Hospital Roswell Park Cancer Institute in Buffalo, New York From

UC and TI-Funding 23 current TI funded projects at UC campuses –All funded by Philip Morris USA –Total $: 16,647,661 in funding –Total UC research funding in FY 2006: $4 billion –$39 million in total funding from 113 total TI funded projects among the UC campuses since gifts from TI to UC campuses –Total $: 485,000 between 1/2005 – 6/2007 –Total UC gifts in FY 2006: $1.29 billion From UCOP, 2007

TI-Funded UC Projects From UCOP, 2007

TI-Funding Debate at UC Individual UC units implement tobacco industry funding bans Individual UC units implement tobacco industry funding bans –UC Berkeley: School of Public Health (2004) –UC Los Angeles: School of Nursing (2004) –UC San Diego: Cancer Center (2004) –UC San Diego: Department of Family and Preventative Medicine (2003) –UC San Francisco: Cancer Center (2003) –UC San Francisco: Institute for Health Policy Studies (2005) 2005: UC Academic Assembly overturn individual UC unit policies. States only the UC Regents can adopt policies to decline funding based on source 1/2007: Regents ban on tobacco industry funding proposed (RE-89) 4/2007: 8 of 10 UC campus Academic Senates vote to oppose RE-89 (UCSF approves, UC Merced abstains) 9/2007: UC Regents adopt a compromise version of RE-89 From UCOP, 2007

TI-Funding Bans: Issues Academic Freedom “slippery slope”: Although the tobacco industry is bad, other funding sources may be singled out solely based on political winds accepting funding from a corporate sponsor is not an endorsement of the corporate sponsor’s products or actions individual investigators and the peer review system can ensure the integrity of research regardless of the source of its funding

Can we count on individual disclosure or peer review? Conflict-of-interest disclosures often are inadequate to describe relationships –Many researchers are not familiar with their own institution’s policies (Boyd et al, 2003) –Scientific journal financial disclosure statement requirements are too general to identify actual funding arrangements (Bero et al, 2005) –Example: Enstrom & Kabat, 2003

Bero et al. Tob Control 2005 Disclosure published in BMJ that met BMJ’s standards Findings from tobacco industry documents and other sources that go beyond what was required by BMJ "The American Cancer Society (ACS) initiated CPS-I in 1959, conducted follow up until 1972, and has maintained the original database" ACS epidemiologists repeatedly cautioned Enstrom before he began the study that the CPS-I dataset was not appropriate to investigate the effects of environmental tobacco smoke (ETS) 21 "Extended follow up until 1997 was conducted at the University of California at Los Angeles with initial support from the Tobacco-Related Disease Research Program, a University of California research organisation funded by the Proposition 99 cigarette surtax. After continuing support from the Tobacco- Related Disease Research program was denied, Dr Enstrom’s application for continued funding from the California Tobacco-Related Disease Research Program was not funded because it had inadequate scientific merit in a year when the program’s budget was drastically reduced. 22 follow up through 1999 and data analysis were conducted at University of California at Los Angeles with support from the Center for Indoor Air Research, a 1988–99 research organisation that receive funding primarily from US tobacco companies" The Center for Indoor Air Research funded grants that were peer reviewed by scientists and "special projects" that were reviewed by tobacco industry lawyers and executives. 38 The CPS-I analysis was funded through the same mechanism as the special projects "In recent years JEE has received funds originating from the tobacco industry for his tobacco related epidemiological research because it has been impossible for him to obtain equivalent funds from other sources" JEE sought research funding from the tobacco industry beginning in 1975 and received his first funding in He has also received funding for serving as an expert witness, reviewing dissertation and grant proposals "GCK never received funds originating from the tobacco industry until last year, when he conducted an epidemiological review for a law firm which has several tobacco companies as clients. He has served as a consultant to the University of California at Los Angeles for this paper" GCK has had an ongoing indirect relationship with the tobacco industry since at least 1981 though his collaborations with Ernst Wynder whose American Health Foundation was funded by Philip Morris. "JEE and GCK have no other competing interests. They are both lifelong non-smokers whose primary interest is an accurate determination of the health effects of tobacco." The analysis of the CPS-I dataset was also funded by Philip Morris tobacco company and this was not disclosed

UC Regents Policy Scientific review and Chancellor approval of research proposals prior to submission to TI for funding –reviewed by a Chancellor-designated scientific review committee drawn from the community of scholars –committee advises the Chancellor whether the proposed study uses sounds methodology and appears designed to allow the researcher to reach objective and scientifically valid conclusions –approved by the Chancellor, who will use the committee recommendations as part of the decision-making process Annual report to UC Regents on proposals –number submitted to the scientific review committees –number approved by the Chancellors –number funded by the tobacco industry –description or abstract of each proposal From UCOP, 2007

UC Regent Policy: Little Impact Policy focuses only on the initial proposal –will only detect initially flawed research that could be manipulated by the tobacco industry –does not review ongoing work or identify any manipulation of the findings afterward TI-funded research may actually increase –scientists may feel projects are “sanctioned” by the new process –public reporting to UC Regents may uncover effects